World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
53218
World Ranking
4049
National Ranking
113

Overview

Stephen B. Fox is affiliated with the Peter MacCallum Cancer Centre in Australia and has contributed extensively to research in medicine, particularly in oncology and molecular biology. Their work focuses on areas such as cancer genomics and diagnostics, breast cancer treatment studies, and cancer immunotherapy and biomarkers.

The scientist's recent publications demonstrate a concentration on breast cancer and cancer biomarkers. Significant papers include:

  • The 2019 World Health Organization classification of tumours of the breast (2020, Histopathology)
  • The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice (2020, The Journal of Pathology)
  • Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (2020, npj Breast Cancer)
  • Male breast cancer: an update (2021, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin)
  • CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence (2020, EBioMedicine)

Frequent coauthors in their research include:

  • Andrew Fellowes
  • Huiling Xu
  • David J. Byrne
  • Jayesh Desai
  • Sunil R. Lakhani

Publications by Stephen B. Fox have appeared predominantly in the following venues:

  • Pathology
  • Histopathology
  • Journal of Clinical Oncology
  • Technology in Society
  • The Journal of Pathology

Their published work spans several key fields and subfields:

  • Main Fields: Medicine, Biochemistry, Genetics and Molecular Biology
  • Subfields: Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Molecular Biology

Main topics of their research include:

  • Cancer Genomics and Diagnostics
  • Breast Cancer Treatment Studies
  • Cancer Immunotherapy and Biomarkers
  • Breast Lesions and Carcinomas
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Diagnosis and Treatment
  • BRCA gene mutations in cancer

Best Publications

  • Breast cancer classification and prognosis based on gene expression profiles from a population-based study

    Christos Sotiriou;Soek-Ying Neo;Lisa M McShane;Edward L Korn

  • Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

    Elgene Lim;Elgene Lim;Francois Vaillant;Di Wu;Di Wu;Natasha C Forrest

  • Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

    Richard W Tothill;Anna V Tinker;Joshy George;Robert Brown

  • Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.

    D. Ross Camidge;Yung Jue Bang;Eunice L. Kwak;A. John Iafrate

  • Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

    Gaynor J. Bates;Stephen B. Fox;Cheng Han;Russell D. Leek

  • BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

    Kathryn Alsop;Sian Fereday;Cliff Meldrum;Anna deFazio

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

    Peter Savas;Balaji Virassamy;Chengzhong Ye;Agus Salim;Agus Salim

  • Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.

    Micheie Relf;Susan LeJeune;Prudence A. E. Scott;Stephen Fox

  • Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

    P. E. Vermeulen;G. Gasparini;S. B. Fox;Masakazu Toi

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial

    Danny Rischin;Richard J. Young;Richard Fisher;Stephen B. Fox

  • Lymphangiogenesis and lymphatic vessel remodelling in cancer

    Steven A Stacker;Steven P Williams;Tara Karnezis;Ramin Shayan

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.

    P.B. Vermeulen;G. Gasparini;S.B. Fox;C. Colpaert

  • The 2019 World Health Organization classification of tumours of the breast.

    Puay Hoon Tan;Ian Ellis;Kimberly Allison;Edi Brogi

  • Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis.

    Stephen B. Fox;Russel D. Leek;Michael P. Weekes;Ruth M. Whitehouse

  • Thymidine phosphorylase is angiogenic and promotes tumor growth.

    Amir Moghaddam;Hua-Tang Zhang;Tai-Ping D. Fan;De-En Hu

Frequent Co-Authors

adrian l harris
adrian l harris University of Oxford
Alexander Dobrovic
Alexander Dobrovic University of Melbourne
Sunil R. Lakhani
Sunil R. Lakhani University of Queensland
Ian G. Campbell
Ian G. Campbell Peter MacCallum Cancer Centre
Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
David D.L. Bowtell
David D.L. Bowtell Peter MacCallum Cancer Centre
Grant A. McArthur
Grant A. McArthur Peter MacCallum Cancer Centre
Benjamin Solomon
Benjamin Solomon Peter MacCallum Cancer Centre
Ygal Haupt
Ygal Haupt Peter MacCallum Cancer Centre
Alfredo Berruti
Alfredo Berruti University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens the door to diverse educational journeys. Online degrees now make it easier than ever to enter or advance in healthcare, providing flexibility for working professionals and students alike.

For those interested in healthcare administration, cahme accredited online mha programs offer accredited paths to leadership roles in hospitals and health systems. Nursing professionals looking to upgrade their credentials may consider rn bsn online programs no clinicals, which provide a convenient path from RN to BSN without mandatory in-person clinical work.

Those aiming for advanced practice or clinical leadership may be interested in graduate nursing programs. Options like the fastest msn to dnp program allow for accelerated completion for MSN-prepared nurses. If flexibility and workload are top considerations, many choose among the easiest dnp programs to further their careers with manageable course demands.

As medical education continues to evolve, these online options give future healthcare leaders multiple pathways and the opportunity to tailor their academic journey.

Best Scientists Citing Stephen B. Fox

Trending Scientists